Skip to main content
NVDA+0.21%AAPL-0.23%GOOGL+0.30%MSFT-0.42%AMZN-0.29%TSM+0.17%SPCX-4.21%META+0.03%AVGO+0.73%TSLA-0.15%BRK-B+0.61%SKHY-3.19%LLY-1.36%MU+0.27%AMD+1.90%WMT-0.71%JPM-0.86%V+1.74%XOM+1.12%ASMLa-4.20%JNJ-5.73%MA+1.63%INTC+1.44%0700.HK-0.03%ABBV-2.40%1398.HK-1.41%CSCO-0.23%CVX+1.27%COST-0.50%ORCL+4.23%KO+0.36%BAC-1.14%DELL-0.72%LRCX-2.73%AMAT-6.69%PG-0.10%AP2d-8.45%CAT-3.33%UNH-0.20%3988.HK-1.16%1816.HK-25.11%0005.HK-1.09%HSBA.L+0.17%0857.HK+0.29%GE-0.33%PM-1.34%0939.HK-1.63%1288.HK-2.19%MS-1.78%NFLX-0.21%CADCHF+0.60%GBPCHF+0.52%AUDCHF+0.46%NZDCHF+0.44%GBPTRY+0.41%USDCAD-0.40%EURCAD-0.35%GBPHKD+0.32%AUDSGD+0.31%GBPUSD+0.31%CADJPY+0.29%NZDSGD+0.29%CHFJPY-0.29%GBPMXN-0.28%USDTRY+0.28%NZDUSD+0.27%AUDUSD+0.27%USDNOK-0.26%EURCHF+0.25%EURGBP-0.23%NZDMXN+0.23%USDZAR-0.21%GBPJPY+0.21%GBPSGD+0.20%USDCHF+0.20%EURAUD-0.18%USDPLN-0.17%AUDJPY+0.17%USDSEK-0.16%EURNOK-0.16%USDILS+0.16%NZDCAD-0.16%EURNZD-0.16%CHFNOK-0.16%CHFSGD+0.16%AUDDKK+0.16%NOKJPY+0.16%SGDJPY-0.16%NZDJPY+0.15%EURSGD+0.15%AUDCAD-0.13%EURZAR-0.11%EURHKD+0.10%USDDKK-0.10%USDJPY-0.10%GBPCAD-0.08%GBPZAR-0.07%EURCNH+0.07%EURPLN-0.07%EURSEK-0.07%EURUSD+0.06%CHFSEK-0.06%PLNJPY+0.06%GBPAUD+0.06%USDSGD+0.05%GBPNZD+0.04%USDCOP-0.04%USDCNH-0.03%EURJPY-0.03%AUDNZD+0.02%USDTHB+0.02%USDMXN-0.01%EURCZK+0.01%USDHKD+0.01%AUDNOK0.00%EURDKK0.00%COTTON+0.73%HG1+0.72%S1+0.48%XNGUSD+0.32%W1-0.24%XAGUSD+0.22%GAGUSD+0.22%UKOIL-0.16%USOIL-0.14%XAUUSD+0.11%GAUUSD+0.11%XPTUSD+0.05%BTCUSD+2.42%ETHUSD+17.67%USDTUSD+0.02%XRPUSD+11.86%SOLUSD+12.05%TRXUSDT+0.77%ZECUSDT+8.52%DOGEUSD+14.12%XMRUSDT+5.79%LINKUSD+13.42%XLMUSD+0.25%BCHUSDT+5.89%UNIUSD+7.49%LTCUSD+9.66%SUIUSD+3.36%HBARUSDT+0.40%TONUSD+26.15%TAOUSDT+3.79%AAVEUSD+3.57%DOTUSDT-0.20%ICPUSDT+0.88%ONDOUSDT+0.38%WLDUSDT-0.21%ARBUSDT+6.76%JUPUSDT+0.62%ATOMUSDT+1.90%INJUSDT+13.23%STXUSDT+6.76%FETUSDT+2.77%TIAUSDT+9.19%PYTHUSDT-0.84%SEIUSDT+4.57%IMXUSDT+0.63%OPUSDT+18.94%GRTUSDT+4.09%IOTAUSDT+0.86%WIFUSDT+2.70%AXSUSDT-1.83%POLUSDT+2.78%FARTCOINUSDT+0.63%EOSUSDT+2.75%DYDXUSDT+3.35%GALAUSDT-1.87%ORDIUSDT-0.12%RONINUSDT-3.42%NOTUSDT+1.21%NVDA+0.21%AAPL-0.23%GOOGL+0.30%MSFT-0.42%AMZN-0.29%TSM+0.17%SPCX-4.21%META+0.03%AVGO+0.73%TSLA-0.15%BRK-B+0.61%SKHY-3.19%LLY-1.36%MU+0.27%AMD+1.90%WMT-0.71%JPM-0.86%V+1.74%XOM+1.12%ASMLa-4.20%JNJ-5.73%MA+1.63%INTC+1.44%0700.HK-0.03%ABBV-2.40%1398.HK-1.41%CSCO-0.23%CVX+1.27%COST-0.50%ORCL+4.23%KO+0.36%BAC-1.14%DELL-0.72%LRCX-2.73%AMAT-6.69%PG-0.10%AP2d-8.45%CAT-3.33%UNH-0.20%3988.HK-1.16%1816.HK-25.11%0005.HK-1.09%HSBA.L+0.17%0857.HK+0.29%GE-0.33%PM-1.34%0939.HK-1.63%1288.HK-2.19%MS-1.78%NFLX-0.21%CADCHF+0.60%GBPCHF+0.52%AUDCHF+0.46%NZDCHF+0.44%GBPTRY+0.41%USDCAD-0.40%EURCAD-0.35%GBPHKD+0.32%AUDSGD+0.31%GBPUSD+0.31%CADJPY+0.29%NZDSGD+0.29%CHFJPY-0.29%GBPMXN-0.28%USDTRY+0.28%NZDUSD+0.27%AUDUSD+0.27%USDNOK-0.26%EURCHF+0.25%EURGBP-0.23%NZDMXN+0.23%USDZAR-0.21%GBPJPY+0.21%GBPSGD+0.20%USDCHF+0.20%EURAUD-0.18%USDPLN-0.17%AUDJPY+0.17%USDSEK-0.16%EURNOK-0.16%USDILS+0.16%NZDCAD-0.16%EURNZD-0.16%CHFNOK-0.16%CHFSGD+0.16%AUDDKK+0.16%NOKJPY+0.16%SGDJPY-0.16%NZDJPY+0.15%EURSGD+0.15%AUDCAD-0.13%EURZAR-0.11%EURHKD+0.10%USDDKK-0.10%USDJPY-0.10%GBPCAD-0.08%GBPZAR-0.07%EURCNH+0.07%EURPLN-0.07%EURSEK-0.07%EURUSD+0.06%CHFSEK-0.06%PLNJPY+0.06%GBPAUD+0.06%USDSGD+0.05%GBPNZD+0.04%USDCOP-0.04%USDCNH-0.03%EURJPY-0.03%AUDNZD+0.02%USDTHB+0.02%USDMXN-0.01%EURCZK+0.01%USDHKD+0.01%AUDNOK0.00%EURDKK0.00%COTTON+0.73%HG1+0.72%S1+0.48%XNGUSD+0.32%W1-0.24%XAGUSD+0.22%GAGUSD+0.22%UKOIL-0.16%USOIL-0.14%XAUUSD+0.11%GAUUSD+0.11%XPTUSD+0.05%BTCUSD+2.42%ETHUSD+17.67%USDTUSD+0.02%XRPUSD+11.86%SOLUSD+12.05%TRXUSDT+0.77%ZECUSDT+8.52%DOGEUSD+14.12%XMRUSDT+5.79%LINKUSD+13.42%XLMUSD+0.25%BCHUSDT+5.89%UNIUSD+7.49%LTCUSD+9.66%SUIUSD+3.36%HBARUSDT+0.40%TONUSD+26.15%TAOUSDT+3.79%AAVEUSD+3.57%DOTUSDT-0.20%ICPUSDT+0.88%ONDOUSDT+0.38%WLDUSDT-0.21%ARBUSDT+6.76%JUPUSDT+0.62%ATOMUSDT+1.90%INJUSDT+13.23%STXUSDT+6.76%FETUSDT+2.77%TIAUSDT+9.19%PYTHUSDT-0.84%SEIUSDT+4.57%IMXUSDT+0.63%OPUSDT+18.94%GRTUSDT+4.09%IOTAUSDT+0.86%WIFUSDT+2.70%AXSUSDT-1.83%POLUSDT+2.78%FARTCOINUSDT+0.63%EOSUSDT+2.75%DYDXUSDT+3.35%GALAUSDT-1.87%ORDIUSDT-0.12%RONINUSDT-3.42%NOTUSDT+1.21%
ER

Erasca, Inc. (ERAS)

NASDAQ • Healthcare

$14.78
-$0.68 (-4.4%)
Market closed

Last close at October 13, 2026 at 20:00 UTC

Open$15.25
Day Range$14.5 - $15.58
Avg. Volume (3M)5.4M
Market Cap$5.1B
52 Week Range
$2.11$24.28
Next EarningsIn 28 daysNov 11, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$287.2M
EPS (TTM)
-$0.95
ROA (TTM)
-66.02%
Current Ratio
8.29

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+9.1%Q1 2026-$0.1
-438.0%Q2 2026-$0.6
-25.7%Q3 2026-$0.14
Next

Nov 11

in 28 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -25.7%

Erasca’s EPS trailed consensus in the second fiscal quarter of 2026, with preliminary results reported August 12 showing EPS of -$0.14 versus a -$0.11 estimate, -26%, and down 16.7% from -$0.12 a year ago. Operating loss came to about $47.6 million, net income was negative roughly $44.1 million, down 30.1% from negative $33.9 million a year earlier, and operating cash flow was negative about $27.3 million. Consensus for the next period calls for EPS of USD -0.13.

Next report — what to expect

Erasca, Inc. (ERAS) is set to report earnings on November 11, 2026. Wall Street is looking for consensus EPS of -$0.13. ERAS has beaten EPS in 4 of 8 most recent quarters, so traders may focus on updates that could influence near-term expense trends and cash runway alongside the headline loss.

View full earnings history

About Erasca, Inc.

Erasca, Inc. is a NASDAQ-listed biotechnology company developing cancer therapies aimed at tumors driven by the RAS/MAPK pathway. The company operates as an early-stage drug developer in the healthcare sector and has built its business around a pipeline of candidates for difficult-to-treat malignancies.

Name
Erasca, Inc.
CEO
Jonathan E. Lim
Website
www.erasca.com
Industry
Healthcare
Year Founded
2018
Employees
103

Today's Snapshot

AI-generated

ERAS closed 4.4% below yesterday's close, in line with a weaker sector.

Trading Volume

Below 10d avg (5.7M)

5M

vs S&P 500 Today

Strong Underperformance

-4.38%

Updated: October 13, 2026 at 20:24 UTC

ERAS Headlines

Biotech & AI Fuel Big Stock Moves

January 20, 2026

5 min read
View All News

Technical Indicators

1 Buy3 Neutral4 Sell
ERAS shows a cautious-to-bearish profile, as price sits below most short and intermediate moving averages and under the classic pivot, while momentum is weak with a negative MACD and muted RSI. Trend strength is not pronounced with ADX in a low-to-moderate range, but volatility is elevated—ATR is about 1.01—adding downside risk to moves. Volume trends are unfavorable with OBV signaling distribution, and although the 200-day average lies slightly below price, the preponderance of short- and medium-term sell signals supports a negative bias. Technical takeaway: Sell.
All signals
  • EMA (5 indicators)$13.04 - $15.85
    Sell
  • RSI (14)45.23
    Neutral
  • Stochastic %K (14, 3, 3)70.80
    Neutral
  • MACD Level (12, 26)-0.33
    Neutral

Peers & Related Assets

RVMDRevolution Medicines, Inc.
$188.44-2.8%
TNGXTango Therapeutics, Inc.
$22.22-8.1%
IDYAIDEAYA Biosciences, Inc.
$34.26-5.0%
NUVBNuvation Bio Inc.
$4.72-3.7%
ORICORIC Pharmaceuticals, Inc.
$11.31-4.2%
KURAKura Oncology, Inc.
$9.83-5.5%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.